• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of comprehensive geriatric assessment-oriented treatment strategy for elderly cancer patients

Research Project

Project/Area Number 23501318
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Clinical oncology
Research InstitutionFukuoka University

Principal Investigator

TAKAMATSU Yasushi  福岡大学, 医学部, 准教授 (50320297)

Co-Investigator(Kenkyū-buntansha) TAMURA Kazuo  福岡大学, 医学部, 教授 (60145422)
Project Period (FY) 2011-04-28 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords高齢者 / がん薬物療法 / 包括的機能評価 / 日常生活の質 / 外来化学療法 / 機能評価 / 薬物動態
Outline of Final Research Achievements

Older patients of same chronologic ages differ widely in physical and psychological function. Treatment strategy should be altered according to functional assessments of each patient. We underwent the comprehensive geriatric assessment (CGA), including psychological status, activities of daily living (ADL), instrumental ADL (IADL), nutritional status, comorbidity and cognitive function in patients with newly diagnosed malignant lymphoma. High ages, advanced stages and severe comorbidities were significantly associated with high incidence of treatment discontinuation, while high ages, ADL-dependencies and accumulation of severe comorbidities were significantly associated with low complete remission (CR) rates. ADL-dependency was significantly associated with overall survival. Performance status was not associated with either CR rate or OS. It indicates that CGA is an effective tool for predicting clinical outcomes in elderly patients who received anti-cancer chemotherapy.

Report

(5 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (53 results)

All 2014 2013 2012 2011 Other

All Journal Article (24 results) (of which Peer Reviewed: 24 results) Presentation (17 results) Book (12 results)

  • [Journal Article] Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy.2014

    • Author(s)
      Ikari Y, Ogata K, Nakashima Y, Sato E, Masaki M, Katsuya H, Goto T, Tanaka T, Ishitsuka K, Takamatsu Y, Hara S, Tamura K.
    • Journal Title

      Support Care Cancer

      Volume: 22 Issue: 7 Pages: 1959-1964

    • DOI

      10.1007/s00520-014-2179-2

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up.2014

    • Author(s)
      Fujisawa S, Nakamae H, Ogura M, Ishizawa K, Taniwaki M, Utsunomiya A, Matsue K, Takamatsu Y, Usuki K, Tanimoto M, Ishida Y, Akiyama H, Onishi S.
    • Journal Title

      Int J Hematol

      Volume: 99 Issue: 2 Pages: 141-153

    • DOI

      10.1007/s12185-013-1470-1

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.2014

    • Author(s)
      Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K, Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya J, Inagaki H, Tamura K, Akinaga S, Tomonaga M, Ueda R.
    • Journal Title

      J Clin Oncol

      Volume: 32 Issue: 11 Pages: 1157-1163

    • DOI

      10.1200/jco.2013.52.0924

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).2014

    • Author(s)
      Fukushima T, Nomura S, Shimoyama M, Shibata T, Imaizumi Y, Moriuchi Y, Tomoyose T, Uozumi K, Kobayashi Y, Fukushima N, Utsunomiya A, Tara M, Nosaka K, Hidaka M, Uike N, Yoshida S, Tamura K, Ishitsuka K, Kurosawa M, Nakata M, Fukuda H, Hotta T, Tobinai K, Tsukasaki K.
    • Journal Title

      Br J Haematol

      Volume: 166 Issue: 5 Pages: 739-748

    • DOI

      10.1111/bjh.12962

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Promise of combining a Bcl-2 family inhibitor with bortezomib or SAHA for adult T-cell leukemia/lymphoma.2014

    • Author(s)
      Kunami N, Katsuya H, Nogami R, Ishitsuka K, Tamura K.
    • Journal Title

      Anticancer Res

      Volume: 34 Pages: 5287-5294

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Osteosarcoma of the patella mimicking giant cell tumor: imaging features with histopathological correlation.2014

    • Author(s)
      Aoki M, Nishio J, Iwasaki H, Masaki M, Kawakami Y, Nishino T, Ohjimi H, Tamura K, Nabeshima K, Naito M.
    • Journal Title

      Anticancer Res

      Volume: 34 Pages: 2541-2545

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study2013

    • Author(s)
      Takamatsu Y, Sunami K, Muta T, Morimoto H, Miyamoto T, Higuchi M, Uozumi K, Hata H, Tamura K
    • Journal Title

      Int J Hematol

      Volume: 98 Issue: 2 Pages: 179-185

    • DOI

      10.1007/s12185-013-1389-6

    • NAID

      10031194733

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma2013

    • Author(s)
      Muta T, Miyamoto T, Fujisaki T, Ohno Y, Kamimura T, Kato K, Takenaka K, Iwasaki H, Eto T, Takamatsu Y, Teshima T, Akashi K
    • Journal Title

      Intern Med

      Volume: 52 Pages: 63-70

    • NAID

      130003365558

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL : results of a prospective study (ALL MRD2002 Study)2013

    • Author(s)
      Nagafuji K, Miyamoto T, Eto T, Kamimura T, Taniguchi S, Okamura T, Ohtsuka E, Yoshida T, Higuchi M, Yoshimoto G, Fujisaki T, Abe Y, Takamatsu Y, Yokota S, Akashi K, Harada M. (16名, 6番目)
    • Journal Title

      J Hematol Oncol

      Volume: 6 Issue: 1 Pages: 14-14

    • DOI

      10.1186/1756-8722-6-14

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission2013

    • Author(s)
      Eto T, Takase K, Miyamoto T, Ohno Y, Kamimura T, Nagafuji K, Takamatsu Y, Teshima T, Gondo H, Taniguchi S, Akashi K, Harada M
    • Journal Title

      Int J Hematol

      Volume: 98 Issue: 2 Pages: 186-196

    • DOI

      10.1007/s12185-013-1378-9

    • NAID

      10031194734

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection2013

    • Author(s)
      Uchiyama M, Takamatsu Y, Ogata K, Matsumoto T, Jimi S, Tamura K, Hara S
    • Journal Title

      Biomed Chromatogr

      Volume: 27 Issue: 7 Pages: 818-820

    • DOI

      10.1002/bmc.2876

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.2013

    • Author(s)
      Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Takamatsu Y, Teshima T, Akashi K.
    • Journal Title

      Int J Hematol

      Volume: 98 Issue: 3 Pages: 337-345

    • DOI

      10.1007/s12185-013-1402-0

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] 多発性骨髄腫患者の末梢血幹細胞採取に対するbortezomibを含む導入療法の影響2013

    • Author(s)
      牟田 毅, 宮本 敏浩, 藤﨑 智明, 大野 裕樹, 上村 智彦, 平安山 知子, 加藤 光次, 竹中 克斗, 岩崎 浩己, 衛藤 徹也, 高松 泰, 豊嶋 崇徳, 赤司 浩一
    • Journal Title

      臨床血液

      Volume: 54 Pages: 109-116

    • NAID

      10031147827

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] セビメリン含嗽液の唾液分泌促進作用に関する研究2013

    • Author(s)
      吉川千鶴子, 高松泰, 緒方憲太郎, 原周司, 田村和夫
    • Journal Title

      癌と化学療法

      Volume: 40 Pages: 215-219

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission2012

    • Author(s)
      Usuki K, Kurosawa S, Uchida N, Yakushiji K, Waki F, Matsuishi E, Kagawa K, Furukawa T, Maeda Y, Shimoyama M, Ago H, Yamano Y, Yano S, Fujishima N, Takamatsu Y, et al
    • Journal Title

      Lymphoma Myeloma Leuk

      Volume: 12 Issue: 6 Pages: 444-451

    • DOI

      10.1016/j.clml.2012.07.004

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Neoadjuvant epirubicin/docetaxel (ET) concomitant chemotherapy for primary breast cancer with tumor diameter >=3.1 cm: results of the Kyushu ET therapy phase II trial2012

    • Author(s)
      Nishimura R, Rai Y, Matsuo F, Anan K, Hara S, Imamura S, Itoyanagi N, Kato M, Okido M, Kudaka M, Ishikawa E, Kamada Y, Watanabe R, Shirouzu M, Mitsuyama S, Takamatsu Y, Tamura K
    • Journal Title

      Anticancer Res

      Volume: 32 Pages: 3259-3265

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin2012

    • Author(s)
      Matsumoto T, Jimi S, Hara S, Takamatsu Y, Suzumiya J, Tamura K
    • Journal Title

      Leuk Lymphoma

      Volume: 53 Issue: 7 Pages: 1399-1405

    • DOI

      10.3109/10428194.2012.656102

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission2012

    • Author(s)
      Yanada M, Kurosawa S, Yamaguchi T, Yamashita T, Moriuchi Y, Ago H, Takeuchi J, Nakamae H, Taguchi J, Sakura T, Takamatsu Y, Waki F, Yokoyama H, Watanabe M, Emi N, Fukuda T
    • Journal Title

      Haematologica

      Volume: 97 Issue: 6 Pages: 915-918

    • DOI

      10.3324/haematol.2011.058289

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction2012

    • Author(s)
      Uchiyama M, Matsumoto T, Matsumoto T, Jimi S, Takamatsu Y, Tamura K, Hara S
    • Journal Title

      Biomed Chromatogr

      Volume: 26 Issue: 1 Pages: 76-80

    • DOI

      10.1002/bmc.1628

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] HPLCによる簡便なミトタン血中濃度測定法の開発および適用2012

    • Author(s)
      内山将伸, 原周司, 緒方憲太郎, 今村健, 高松泰, 田村和夫, 二神幸次郎
    • Journal Title

      医療薬学

      Volume: 38 Pages: 191-195

    • NAID

      130004894810

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] 骨髄腫に対する初回治療として新規薬剤を全例に用いる必要はない2012

    • Author(s)
      高松泰
    • Journal Title

      臨床血液

      Volume: 53 Pages: 587-593

    • NAID

      10030831490

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review2011

    • Author(s)
      Kamimura T, Miyamoto T, Nagafuji K, Numata A, Henzan H, Takase K, Ito Y, Ohno Y, Fujisaki T, Eto T, Takamatsu Y, Teshima T, Gondo H, Akashi K, Taniguchi S, Harada M
    • Journal Title

      Bone Marrow Transplant

      Volume: 46 Pages: 820-826

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia2011

    • Author(s)
      Kunishima S, Kashiwagi H, Otsu M, Takayama N, Eto K, Onodera M, Miyajima Y, Takamatsu Y, Suzumiya J, Matsubara K, Tomiyama Y, Saito H
    • Journal Title

      Blood

      Volume: 117 Pages: 5479-5484

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Fluorescence in situ hybridization (FISH)の末梢血塗抹標本への応用2011

    • Author(s)
      生田幹博, 大神明子, 高松泰, 阿南建一, 三浦偉久男, 加藤純子, 石田寛美, 二田優子, 川島博信, 松永彰
    • Journal Title

      福岡医学雑誌

      Volume: 102 Pages: 318-324

    • NAID

      40019177299

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Presentation] Predictive Significance of Serum Beta-2-Microglobulin levels and M-Protein.2014

    • Author(s)
      Muta T, Iida S, Matsue K, Sunami K, Isoda J, Harada N, Saburi Y, Okamura S, Kumagae K, Watanabe J, Kuroda J, Aoki K, Ogawa R, Miyamoto T, Akashi K, Takamatsu Y.
    • Organizer
      The 56th Annual Meeting of American Society of Hematology
    • Place of Presentation
      サンフランシスコ, 米国
    • Year and Date
      2014-12-07
    • Related Report
      2014 Annual Research Report
  • [Presentation] Clinical courses and risk-predicting factors of progression in smoldering multiple myeloma; a nationwide cohort study in Japan.2014

    • Author(s)
      高松 泰
    • Organizer
      第76回日本血液学会/シンポジウム2
    • Place of Presentation
      大阪
    • Year and Date
      2014-10-30
    • Related Report
      2014 Annual Research Report
  • [Presentation] 悪性リンパ腫の疾患概念と治療.2014

    • Author(s)
      高松 泰
    • Organizer
      第33回日本乳腺甲状腺超音波医学会/教育委員会企画
    • Place of Presentation
      別府
    • Year and Date
      2014-10-19
    • Related Report
      2014 Annual Research Report
  • [Presentation] Early treatment for smoldering multiple myeloma.2014

    • Author(s)
      高松 泰
    • Organizer
      第12回日本臨床腫瘍学会/シンポジウム1
    • Place of Presentation
      福岡
    • Year and Date
      2014-08-17
    • Related Report
      2014 Annual Research Report
  • [Presentation] Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed myeloma2011

    • Author(s)
      Takamatsu Y, Sunami K, Muta T, Tsukada J, Miyamoto T, Eto T, Higuchi M, Hata H, Hidaka M, Uozumi K, Otsuka E, Ogata M, Matsuoka H, Tamura K
    • Organizer
      第73回日本血液学会総会
    • Place of Presentation
      名古屋
    • Related Report
      2011 Research-status Report
  • [Presentation] 骨髄腫に対する初回治療として新規薬剤を全例に用いる必要はない2011

    • Author(s)
      高松泰
    • Organizer
      第73回日本血液学会総会 シンポジウム7
    • Place of Presentation
      名古屋
    • Related Report
      2011 Research-status Report
  • [Presentation] A phase I/II study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory myeloma2011

    • Author(s)
      Takamatsu Y, Sunami K, Muta T, Tsukada J, Miyamoto T, Eto T, Higuchi M, Hata H, Hidaka M, Uozumi K, Otsuka E, Ogata M, Matsuoka H, Tamura K
    • Organizer
      第36回日本骨髄腫研究会
    • Place of Presentation
      東京
    • Related Report
      2011 Research-status Report
  • [Presentation] 多発性骨髄腫に対するボルテゾミブを用いた至適レジメンの検討

    • Author(s)
      高松泰
    • Organizer
      第51回日本癌治療学会・臓器別シンポジウム21
    • Place of Presentation
      京都
    • Related Report
      2013 Research-status Report
  • [Presentation] 血液腫瘍の治療と口腔機能管理

    • Author(s)
      高松泰
    • Organizer
      第23回日本有病者歯科医療学会総会学術大会・シンポジウム2
    • Place of Presentation
      福岡
    • Related Report
      2013 Research-status Report
  • [Presentation] Geriatric assessment for the elderly patients with diffuse large B cell lymphoma (DLBCL) and treatment outcomes

    • Author(s)
      Yasushi Takamatsu, Yoshiko Naito, Eiichi Sato, Yosuke Ikari, Hiroo Katsuya, Toshitaka Goto, Akihiko Shirahashi, Toshihiro Tanaka, Kenji Ishitsuka, and Kazuo Tamura
    • Organizer
      第11回日本臨床腫瘍学会総会
    • Place of Presentation
      仙台
    • Related Report
      2013 Research-status Report
  • [Presentation] 発熱性好中球減少症

    • Author(s)
      高松泰
    • Organizer
      第75回日本血液学会総会教育講演
    • Place of Presentation
      札幌
    • Related Report
      2013 Research-status Report
  • [Presentation] 骨髄腫

    • Author(s)
      高松泰
    • Organizer
      日本臨床腫瘍学会第23回教育セミナー
    • Place of Presentation
      横浜
    • Related Report
      2013 Research-status Report
  • [Presentation] がんと診断された時からの緩和ケアの実践のために~腫瘍内科医の立場から

    • Author(s)
      高松泰
    • Organizer
      第17回日本緩和医療学会学術大会パネルディスカッション7
    • Place of Presentation
      神戸国際展示場
    • Related Report
      2012 Research-status Report
  • [Presentation] 内科専門医の立場から-感染症管理または支持療法のエビデンスの適応について

    • Author(s)
      高松泰
    • Organizer
      第20回日本乳癌学会 日本乳癌学会・日本臨床腫瘍学会合同シンポジウム
    • Place of Presentation
      熊本テトリアくまもとビル
    • Related Report
      2012 Research-status Report
  • [Presentation] Bortezomib in combination with cytotoxic agent therapy for multiple myeloma

    • Author(s)
      Takamatsu Y, Sunami K, Muta T, Tsukada J, Miyamoto T, Eto T, Higuchi M, Hata H, Hidaka M, Uozumi K, Otsuka E, Ogata M, MatsuokaH, Tamura
    • Organizer
      第10回日本臨床腫瘍学会学術集会
    • Place of Presentation
      大阪国際会議場
    • Related Report
      2012 Research-status Report
  • [Presentation] 高齢者びまん性大細胞型B細胞リンパ腫(DLBCL)症例における機能評価と治療との検討

    • Author(s)
      工並 直子、佐々木 秀法、中島 勇太、佐藤 栄一、猪狩 洋介、勝屋 弘雄、後藤 敏孝、茂木 愛、石津 昌直、田中 俊裕、石塚 賢治、高松 泰、田村 和夫
    • Organizer
      第10回日本臨床腫瘍学会学術集会
    • Place of Presentation
      大阪国際会議場
    • Related Report
      2012 Research-status Report
  • [Presentation] 移植適応の多発性骨髄腫患者に対する寛解導入療法

    • Author(s)
      高松泰
    • Organizer
      第35回日本造血細胞移植学会総会・ワークショップ5
    • Place of Presentation
      ANAクラウンプラザホテル金沢
    • Related Report
      2012 Research-status Report
  • [Book] がん治療副作用対策マニュアル2014

    • Author(s)
      田村和夫、緒方健太郎、小田真由美、石塚賢治、中村和正、伊藤敬美、堀田綾美、柴田隆夫、熊川みどり、北野晃祐、岡久美、小河一彦、高松泰、勝屋弘雄
    • Total Pages
      348
    • Publisher
      南江堂
    • Related Report
      2014 Annual Research Report
  • [Book] 移植非適応骨髄腫の治療2014

    • Author(s)
      清水一之、萩原将太郎、齋藤貴之、村上博和、半田寛、島崎千尋、張高明、中村信元、安倍正博、高松泰、麻奥英毅、得平道英、木崎昌弘、小杉浩史、石田禎夫、鈴木憲史
    • Total Pages
      171
    • Publisher
      医薬ジャーナル社
    • Related Report
      2014 Annual Research Report
  • [Book] 多発性骨髄腫Updating第3巻(Risk-adapted approach)2013

    • Author(s)
      高松泰(分担)
    • Total Pages
      183
    • Publisher
      医薬ジャーナル社
    • Related Report
      2013 Research-status Report
  • [Book] 多発性骨髄腫Updating第4巻(タンデム自家移植)2013

    • Author(s)
      高松泰(分担)
    • Total Pages
      203
    • Publisher
      医薬ジャーナル社
    • Related Report
      2013 Research-status Report
  • [Book] 造血器腫瘍診療ガイドライン(慢性リンパ性白血病)2013

    • Author(s)
      高松泰(分担)
    • Total Pages
      328
    • Publisher
      金原出版
    • Related Report
      2013 Research-status Report
  • [Book] プリンシプル血液疾患の臨床-ここまできた白血病/MDS治療(抗がん剤、その他の合併症)2013

    • Author(s)
      高松泰(分担)
    • Total Pages
      340
    • Publisher
      中山書店
    • Related Report
      2013 Research-status Report
  • [Book] チーム医療のための血液がんの標準的化学療法(制吐薬、好中球減少への対応、腫瘍崩壊症候群への対応、ブラッドアクセス、鎮静、疼痛管理)2013

    • Author(s)
      高松泰(分担)
    • Total Pages
      459
    • Publisher
      メデイカルサイエンスインターナショナル社
    • Related Report
      2013 Research-status Report
  • [Book] 血液疾患に伴う合併症対策(5. 発熱性好中球減少症)2013

    • Author(s)
      高松泰(分担)
    • Total Pages
      243
    • Publisher
      医薬ジャーナル社
    • Related Report
      2013 Research-status Report
  • [Book] 新臨床腫瘍学, 改訂第3版, 「高齢者、思春期・青年期のがんとがん医療」2012

    • Author(s)
      日本臨床腫瘍学会編集, 高松泰(分担)
    • Publisher
      南江堂
    • Related Report
      2012 Research-status Report
  • [Book] 発熱性好中球減少症(FN)診療ガイドライン2012

    • Author(s)
      日本臨床腫瘍学会編集, 高松泰(ガイドライン部会長として編集を統括)
    • Total Pages
      70
    • Publisher
      南江堂
    • Related Report
      2012 Research-status Report
  • [Book] 血液専門医テキスト2011

    • Author(s)
      高松泰, 日本血液学会編集
    • Publisher
      南江堂
    • Related Report
      2011 Research-status Report
  • [Book] 白血病診療ポケットブック2011

    • Author(s)
      高松泰, 松村到編
    • Publisher
      中外医学社
    • Related Report
      2011 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi